Intensive Review of Endocrinology and Metabolism 2020

Intensive Review of Endocrinology and Metabolism 2020

CLEVELAND CLINIC BOARD REVIEW

An intensive endocrinology and metabolism board review designed to improve the management and care of patients with endocrine disorders.

Description

Stay Current in a Rapidly Evolving Field

Intensive Review of Endocrinology and Metabolism is a wide-ranging review of endocrine disorders. Led by Cleveland Clinic’s Elias S. Siraj, MD, and Robert S. Zimmerman, MD, FACP, and FACE, this broad online CME course includes case-based lectures on thyroid and pituitary disorders, metabolic bone disease, pediatric endocrinology, diabetes therapeutics, and advanced lipidology, with special focus on the latest developments and treatment methodologies. It will help you to better:

• Appraise the management of endocrine disorders in pediatric patients
• Evaluate and treat patients with gonadal and pituitary disorders
• Outline management strategies for patients with oncologic endocrine disorders
• Summarize management issues for metabolic bone disease, osteoporosis, vitamin D deficiency, and hyper/hypocalcemia
• Describe diabetes complications and the impact of new insulin and incretin therapies
• Pass ABIM board examinations and integrate current knowledge into daily practice

Date of Original Release: December 15, 2020
Date Series Expires: December 15, 2022

Learning Objectives

Upon completion of this activity, the participant will be able to:

• Summarize clinical practice issues associated with thyroid nodules and cancer, hyper- and hypothyroidism, and menopause
• Describe differing management strategies for patients with endocrine hypertension, adrenal insufficiency, congenital adrenal hyperplasia, hypoglycemia, and obesity
• Review case management issues for endocrine surgery and pediatric patients with endocrine disorders
• Describe the potential impact of endocrine disorders in transgender patients
• Summarize diagnosis and management strategies for disorders of the thyroid, pituitary, and adrenal glands
• Summarize management issues for metabolic bone disease, osteoporosis, vitamin D deficiency, and hyper/hypocalcemia
• Explain the different management strategies for male hypogonadism and female hypogonadism
• Describe diabetes complications and the impact of new insulin and incretin therapies

Intended Audience

This review is directed to practicing endocrinologists, fellows, and other healthcare professionals with an interest in endocrinology, metabolism and diabetes.

Topics And Speakers:

• Thyroid Nodules and Cancer – Hossein Gharib, MD

• Hyperthyroidism and Hypothyroidism – Mary Vouyiouklis Kellis, MD

• Thyroid Board Simulation – Victor Bernet, MD

• Board Simulation Potpourri – Kevin Pantalone, DO

• Menopause: A Pause for Thought – Keren Zhou, MD

• Endocrine Hypertension – Richard J, Auchus, MD, PhD

• Cushings and Adrenal Insufficiency – Amir Hamrahian, MD

• Congenital Adrenal Hyperplasia – Donald Zimmerman, MD

• Case Management Studies in Endocrine Surgery – Allan Siperstein, MD

• Hypoglycemia Evaluation – Elias S. Siraj, MD

• Obesity Therapy – Sangeeta Kashyap, MD

• Workshop: Pediatric Endocrinology Case Reviews – Anzar Haider, MD

• Transgender Management – Vin Tangpricha, MD

• Endocrinology and Pregnancy – Adi Mehta, MD

• DI/SIADH – Joseph Verbalis, MD

• Board Simulation: Pituitary/Adrenal – Divya Yogi-Morren, MD

• Pituitary Disorders – Mark Molitch, MD

• Metabolic Bone Disease: Board Simulation – Mario Skugor, MD

• DXA, Osteoporosis and Vitamin D Problems – Angelo Licata, MD, PhD

• Hyper- and Hypocalcemia – Michael A. Levine, MD

• Male Hypogonadism – Charles Faiman, MD

• Female Hypogonadism – Marjan Attaran, MD

• Visual Journey in Endocrinology – Farhad Zangeneh, MD

• Potpourri on Recent Developments in Endocrinology – S. Sethu K. Reddy, MD, MBA

• Endocrine Oncology – Christian Nasr, MD

• Genetics and Endocrinology – S. Sethu K. Reddy, MD, MBA

• Dyslipidemia: Practice Guidelines – Shailendra Patel, MD, PhD

• Advanced Lipidology – Betul Hatipoglu, MD

• Diabetes Therapeutics: From New Insulins to Incretins – Robert S. Zimmerman, MD

• Preventing Diabetes Complications & Intensive Therapy: Board Simulation – Leann Olansky, MD